Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?

Pierluigi Granone, Alfredo Cesario, Patrizia Russo, Candida Nastrucci

Risultato della ricerca: Contributo in rivistaArticolo in rivista

25 Citazioni (Scopus)

Abstract

This paper discusses the potential therapeutic effect of α7-nAChR antagonists for NSCLC (non small cell lung cancer) and MPM (malignant pleural mesothelioma). This therapeutic approach is based on the experimental observations that: (a) functional α7-nAChR are expressed in NSCLC and MPM cells, (b) the activation of these receptors by agonists, namely nicotine, induces cell proliferation and inhibits apoptosis, whereas antagonists have a pro-apoptotic effect. Among competitive α7-nAChR antagonists, d-tubocurarine and -cobratoxin (α-CbT), from the snake venom of Naja, emerged as possible drug candidates. However, some aspects of the samples must be particularly taken into account, such as the particular nature of the sample. Thus, when using natural compounds purified from snake venom, it is important to take into account the factors such as whether the venom sample was derived from different animals, purified by different methods, or contained contaminants of the same molecular weight. Finally, biological activity may be different for different batches, which could also have been stored under different conditions (e.g. temperature, dilution, suspension medium etc.). These factors, affecting the experimental results, are also discussed.
Lingua originaleEnglish
pagine (da-a)688-694
Numero di pagine7
RivistaCURRENT DRUG TARGETS
Stato di pubblicazionePubblicato - 2012

Keywords

  • mesothelioma

Fingerprint Entra nei temi di ricerca di 'Is α7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?'. Insieme formano una fingerprint unica.

Cita questo